Futura Medical (LON:FUM) Stock Price Down 6.8% – Here’s Why

Futura Medical plc (LON:FUM)’s stock price fell 6.8% during mid-day trading on Thursday . The stock traded as low as GBX 0.37 and last traded at GBX 0.45. 3,423,739 shares traded hands during trading, a decline of 63% from the average session volume of 9,355,516 shares. The stock had previously closed at GBX 0.48.

Futura Medical Price Performance

The stock has a market capitalization of £2.62 million, a P/E ratio of -0.16 and a beta of 0.02. The stock has a fifty day moving average price of GBX 0.47 and a 200 day moving average price of GBX 0.88.

Futura Medical Company Profile

Futura Medical plc (AIM: FUM) is the developer of innovative sexual health products, including lead product Eroxon® and products WSD4000 and Eroxon® Intense. Our core strength lies in our research, development and commercialisation of topically delivered gel formulations in sexual health products.

Sexual health issues are prevalent in both men and women. ED impacts 1 in 5 men globally across all adult age brackets, with approximately half of all men over 40 experiencing ED and 25% of all new diagnoses being in men under 40.